GARFIELD Registry

Over 67,000 patients make up the global anticoagulant registry in the field (GARFIELD). The largest prospective AF registry, and a new VTE registry.

[GARFIELD Registry @GARFIELD_reg]

Our paper titled 'Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry' has been published in openheart! Click on the link below to read the full article:
https://t.co/W9V7kNqj2S
#afib #openheart #thrombosis

[GARFIELD Registry @GARFIELD_reg]

@EverydayHealth @thrombosisday A9: National strategies involving VTE risk assessment in all patients admitted to hospital and in antenatal clinics #clotchat #wtday23

[GARFIELD Registry @GARFIELD_reg]

@DrDeSancho @thrombosisday A8: An anticoagulant that treats and prevents VTE without increasing the risk of bleeding; a safe and effective method of treating and preventing PTS #ClotChat #WTDay23

[GARFIELD Registry @GARFIELD_reg]

@EverydayHealth @thrombosisday A7: VTE occurs as a single event rather than as a condition that can recur #ClotChat #WTDay23

[GARFIELD Registry @GARFIELD_reg]

@EverydayHealth @thrombosisday Leg pain or swelling, chest pain, breathless, coughing up blood, unexplained fainting #ClotChat #WTDay23

[GARFIELD Registry @GARFIELD_reg]

@EverydayHealth @thrombosisday A3: There has been substantial improvement amongst clinical staff in particular over the past 10 years as a result of factors including national initiatives and WTD #ClotChat #WTDay23

[GARFIELD Registry @GARFIELD_reg]

@EverydayHealth @thrombosisday A2: Give clear verbal and written information about VTE risks and clinical features to people being admitted to hospital or undergoing surgery #ClotChat #WTDay23

[GARFIELD Registry @GARFIELD_reg]

We have collaborated with the OVID research team in Zurich to see if enoxaparin may benefit COVID-19 patients who are treated in an ambulatory setting - click below to read our paper:

https://t.co/j1rybMwidv

[GARFIELD Registry @GARFIELD_reg]

Patients with AF and type 2 diabetes may have improved health outcomes when taking oral anticoagulants. Read our new paper to find out more...
https://t.co/u5PazDoxH4

[GARFIELD Registry @GARFIELD_reg]

We are pleased to share that our paper titled 'Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD‐AF and ORBIT‐AF registries in Clinical Cardiology' has been published!

https://t.co/jtBiI0ik9f

[GARFIELD Registry @GARFIELD_reg]

Not long to go - see you at ESC!
#thrombosis #Cardiology #afib

[GARFIELD Registry @GARFIELD_reg]

A fascinating prospective study shows that greater adherence to the EAT-Lancet diet index is associated with a significantly lower risk of incident AF.

https://t.co/EdNL3KTYoy

[GARFIELD Registry @GARFIELD_reg]

A very interesting article about potential new disease models in thrombosis...

https://t.co/ynetCRigBj

[GARFIELD Registry @GARFIELD_reg]

We will be presenting at the ESC congress 2023 in Amsterdam!
Join us on 27th August 9:00-10:00 local time where we will be presenting ‘Patients with AF and dementia are undertreated for their AF and cardiovascular comorbidities: results from the GARFIELD-AF registry’ #ESC2023

[GARFIELD Registry @GARFIELD_reg]

We just published a paper on a important patient population represented in the GARFIELD-AF registry titled 'Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD-AF registry'

https://t.co/3d2cP2ejsV

[GARFIELD Registry @GARFIELD_reg]

We are thrilled to announce that our article titled 'Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF' has been published in the EHJ Open! #guidelines #thrombosis #afib

https://t.co/Es20UucC0o

[GARFIELD Registry @GARFIELD_reg]

We are thrilled to announce that we will be presenting at the ESC congress 2023 in Amsterdam!
Check out our e-poster on 28th August titled ‘Relationship between care speciality and atrial fibrillation outcomes in the GARFIELD-AF registry’ #ESC2023

[GARFIELD Registry @GARFIELD_reg]

We will be presenting at the ESC congress 2023 in Amsterdam!
Join us on 27th August 9:00-10:00 local time where we will be presenting ‘Patients with AF and dementia are undertreated for their AF and cardiovascular comorbidities: results from the GARFIELD-AF registry’ #ESC2023

[GARFIELD Registry @GARFIELD_reg]

We have published another paper looking at healthcare utilization in newly diagnosed AF patients in the US. You can read it here: https://t.co/IsZ0IjZ00y

#garfield #AFib #thrombosis

[GARFIELD Registry @GARFIELD_reg]

Our new paper looking at 36-month clinical outcomes of patients with venous thromboembolism has been published! Read it here: https://t.co/MezcVdoBrW #Garfield